Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Elemental Analyser

By Drug Discovery Trends Editor | July 15, 2010

exeterWith its wide linear range, combined static and dynamic combustion technology and horizontal furnace design allowing for removal of residues between runs, the Exeter Analytical CE-440 CHN/O/S elemental analyzer is uniquely capable of accurately analyzing the widest range of sample types – quickly, easily and reliably.

Whether you are analyzing organic compounds, pharmaceuticals, petrochemicals, polymers, refractory, environmental or natural materials (soil, plants or insects), determining the percentage Carbon, Hydrogen, Nitrogen, Oxygen and Sulphur in your sample is a basic and essential need.

Employing the combined combustion technique makes it possible for the CE-440 to analyse any sample type, from volatiles to difficult to combust materials including nitrides, graphite fibers, ceramics and even carbides with melting points of over 2000°C.

Offering unmatched operating accuracy and precision the fully automated CE440 delivers simultaneous CHN analysis in less than 5 minutes and Oxygen and Sulphur in only 6 minutes – increasing the productivity of your laboratory.
 
Low gas and reagent consumption combined with high reduction tube life allows the CE440 to deliver some of the lowest operating costs of any CHN/O/S elemental analyzer available. Intuitive Windows based operating software reduces human errors through incorporation of extensive automation, comprehensive customer help and diagnostic facilities.  Most parts on the CE440 are user replaceable further reducing operating costs and downtime.

Exeter Analytical


Filed Under: Drug Discovery

 

Related Articles Read More >

Lokavant’s Spectrum v15 uses AI to cut trial-feasibility modeling from weeks to minutes
Prime time for peptide-based drug discovery 
Why smaller, simpler molecular glues are gaining attention in drug discovery
Glass vial, pipette and woman scientist in laboratory for medical study, research or experiment. Test tube, dropper and professional female person with chemical liquid for pharmaceutical innovation
Unlocking ‘bench-to-bedside’ discoveries requires better data sharing and collaboration
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE